ARA
CVS icon

Alexander Randolph Advisory’s CVS Health CVS Stock Holding History

Alexander Randolph Advisory’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.61M Sell
44,562
-13,260
-23% -$1.18M 3.8% 5
2026
Q1 		$4.15M Buy
57,822
+1,110
+2% +$85.5K 3.58% 5
2025
Q4 		$4.5M Sell
56,712
-4
-0% -$315 3.74% 5
2025
Q3 		$4.28M Sell
56,716
-44
-0.1% -$3.02K 3.52% 6
2025
Q2 		$3.92M Sell
56,760
-330
-0.6% -$21.6K 3.51% 7
2025
Q1 		$3.87M Sell
57,090
-2,600
-4% -$156K 3.79% 7
2024
Q4 		$2.68M Buy
59,690
+88
+0.1% +$4.94K 2.48% 13
2024
Q3 		$3.75M Buy
59,602
+4,035
+7% +$235K 3.32% 9
2024
Q2 		$3.28M Sell
55,567
-329
-0.6% -$20.6K 3.07% 10
2024
Q1 		$4.46M Buy
55,896
+45
+0.1% +$3.44K 3.9% 6
2023
Q4 		$4.41M Buy
+55,851
New +$3.98M 4.01% 7

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Alexander Randolph Advisory's CVS Position: Q2 2026 in Review

Alexander Randolph Advisory reduced its CVS Health (CVS) stake by 23% in Q2 2026, selling an estimated $1.18M and leaving 44,562 shares worth $4.61M. The position accounts for 3.8% of the portfolio, ranked #5.

Alexander Randolph Advisory first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Alexander Randolph Advisory held 44,562 shares of CVS Health worth $4.61M as of Q2 2026.
  • Alexander Randolph Advisory sold 13,260 CVS Health shares in Q2 2026, an estimated $1.18M.
  • CVS Health made up 3.8% of Alexander Randolph Advisory's portfolio in Q2 2026, its #5 holding.
  • Alexander Randolph Advisory first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Alexander Randolph Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.